Mustafa Hasan Arif, 37, who also holds the nationality of Britain, defrauded individuals all around the world by selling drugs that he claimed would cure many serious diseases.
According to court documents, Arif's scheme generated more than USD 12.8 million in fraudulent sales from more than 100,000 victims.
He was initially arrested after he flew into New York in February 2014 on a business trip.
Arif pleaded guilty to wire fraud on October 11, 2016.
According to the documents, Arif created, maintained, and controlled over 1,500 websites that promoted the sale of the drugs while he stayed in Lahore.
The websites claimed that the drugs would cure and treat hundreds of diseases, many of which were incurable, including cerebral palsy, mental retardation, Parkinson's disease, Alzheimer's disease and emphysema.
The websites included falsified cure rates, false clinical research and fabricated testimonials, federal prosecutors alleged.
One series of websites fraudulently claimed that Arif's products had shown a 90 per cent cure rate in clinical trials.
In an effort to make customers comfortable about the products, Arif also falsely represented that the drugs were being sold by entities in Germany, Norway, Italy, Australia, New Zealand, and Denmark when in fact the drugs were all being sold and shipped from Pakistan.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
